Latest filing published 01 Dec 2023 for Genscript Biotech Corporation, €578k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Wang Xuehai: trading record in brief
Wang Xuehai discloses dealings in Genscript Biotech Corporation to HKEX. We count 4 filings; the first trade dates from 28 December 2020 and the latest from 28 November 2023.
Both buying and selling appear: 2 purchases, against 1 sale worth €578k. The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2023 to date brings 1 purchase and 1 sale.
The record was last updated on 1 December 2023 with an open-market sale (€578k) in Genscript Biotech Corporation. The last insider purchase was made public on 1 December 2023, 1,074 days ago. The median gap between a trade and its publication by HKEX is 3 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Wang Xuehai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 210,000 shares@ HK$23.5066.0% of flowShareXHKGHKEX:DA20231201E00160
- 210,000 shares@ HK$12.1034.0% of flowShareXHKGHKEX:DA20231201E00159
- 16,957 sharesShareXHKGHKEX:DA20231201E00161Canonical exit: 26 Feb 2024 (T+90)
- 210,000 sharesShareXHKGHKEX:DA20201231E00467Canonical exit: 28 Mar 2021 (T+90)
4 of 4 declarations
